Early liver transplantation improves familial amyloidotic polyneuropathy patients' survival

Amyloid

Volumn 12, Issue 4, 2005, Pages 233-238

  Suhr, Ole B ^a   Friman, Styrbjörn ^b   Ericzon, Bo Göran ^c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloidosis; Hereditary; Liver; Neuropathic; Transplantation; Transthyretin

Indexed keywords

AMYLOID PROTEIN;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL STATUS; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; BODY MASS INDEX; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREALBUMIN; RETROSPECTIVE STUDIES;

EID: 30744434113     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120500363609     Document Type: Article

References (19)

1. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, Karlberg I, Norden G, Nakazato M, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991;40:242-246.
2. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113-1116.
3. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996;47:944-951.
4. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000;123 Pt 7:1495-1504.
5. Suhr OB, Ericzon BG, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002;8:787-794.
6. Suhr OB. Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications. Amyloid: J Protein Folding Disord 2003;10 (Suppl 1):77-83.
7. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998;66:229-233.
8. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998;65:918-925.
9. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F, Ikeda S. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 2000;274:702-706.
10. Olofsson BO, Backman C, Karp K, Suhr OB. Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 2002;73:745-751.
11. Hornsten R, Wiklund U, Olofsson BO, Jensen SM, Suhr OB. Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. Transplantation 2004;78:112-116.
12. Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994;235:479-485.
13. Suhr OB, Herlenius G, Friman S, Ericzon BG. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000;6:263-276.
14. Suhr OB, Ando Y, Holmgren G, Wikstrom L, Friman S, Herlenius G, Ericzon BG. Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transpl Int 1998;11:S160-S163.
15. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj FF, Groth CG, Ericzon BG. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995;60:933-938.
16. Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, Yamashita T, Ando E, Uchino M, Ando M. Outcome of liver transplantation for transthyretin amyloidosis: follow- up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 1999;171:19-23.
17. Jonsen E, Suhr OB, Tashima K, Athlin E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid: Int J Exp Clin Invest 2001;8:52-57.
18. Suhr OB, Wiklund U, Eleborg L, Ando Y, Backman C, Birgersdotter V, Bjerle P, Ericzon BG, Johansson B, Olofsson BO. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation 1997;63:675-679.
19. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand 1976;590(Suppl):1- 64.